Search

everythinglearnresearchcommunity

for

Search:↓

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Women with PCOS have more Bifidobacterium in their gut compared to those without PCOS.

Anti-androgens can help manage some PCOS symptoms better than metformin but are not more effective than placebos or birth control pills for other symptoms.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

More than half of the women with PCOS in Southern India had Metabolic Syndrome, with large waist circumference being the most common feature.

Diagnosing and treating PCOS in teenagers is difficult, and the focus is on lifestyle changes and medication to improve health and prevent future issues.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

Skin problems like acne and excess hair in PCOS are common and linked to being overweight.

Both oral contraceptives reduced hirsutism in PCOS patients, but adding metformin showed no extra benefit.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Women with PCOS are much more likely to experience depression.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

Higher estrone-to-estradiol ratios are linked to worse glucose metabolism and insulin resistance in women with PCOS.

The 2018 guideline for PCOS suggests new diagnostic criteria and treatments, but recognizes the need for more research.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.

Adolescents with abnormal uterine bleeding often have polycystic ovarian syndrome and insulin resistance.

The most common skin problems in polycystic ovarian disease are hirsutism and acne, and managing these symptoms is key for treatment.

The review found that current care models for PCOS are not fully effective and more research is needed, especially in low-income countries.

Eating a Mediterranean diet and taking certain supplements may improve symptoms of PCOS.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Women with PCOS have thicker parafoveal areas in their retinas, but their macular blood vessel density is normal.

Two new reliable Arabic questionnaires for measuring quality of life in women with PCOS were created, one for married and one for unmarried women.

Most women with polycystic ovary syndrome (PCOS) have menstrual issues, infertility, acne, and excessive body hair, with the most common type being the non-androgenic phenotype.